click below
click below
Normal Size Small Size show me how
FORMS/COMPOUNDING
FORMS
Term | Definition |
---|---|
NDC-First Segment | *Drug Manufacturer |
NDC-Second Segment | *Identifies Drug |
NDC-Third Segment | *Package Size |
DEA Form 41 | *Reporting the destruction of controlled substance |
DEA Form 104 | *Pharmacy closure or surrender of permit |
DEA Form 106 | *Reporting loss or theft of controlled substances |
DEA Form 222 | *For ordering C-I and CII |
DEA Form 224 | *Applying DEA registration number |
DEA Form 224a | registration renewal |
First letter identifies type of practitioner A, B, F | *Physicians dentists, veterinarians, pharmacies and hospitals |
First letter identifies type of practitioner M | *Mid-level practitioners, physician assistants, and nurse practitioners |
First letter identifies type of practitioner P and R | *Manufacturers, Distributors, Narcotic treatment programs and researchers |
7 Rights of medication Administration | A. Right Patient B. Right Medication C. Right Dose D. Right Route E. Right Time F. Right Indication G. Right Documentation |
Risk Evaluation and Mitigation (REMS) | *Drug safety program that has strict criteria and procedures on dispensing medications * Requires prescriber and patient registration and consent *Examples Clozapine Isotretinoin |
iPLEDGE | *Helps reduce the risk of severe birth defects with isotretinoin *Anti acne drug |
MedWatch | *Voluntary FDA reporting adverse events |
Adverse Event Reporting System (VAERS) | *Analyze data from adverse events after Vaccination |
USP <795> | *Guidance on good compounding practices in NON-Sterile compounding |
Class A Balance | *Type of balance (scale) that is used for weighing compounding |
Beyond-Use-Date (BUD) | *Date after which compounded medication should not be used *Expiration date and BUD are not the same |